SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0000949353-05-000318
Filing Date
2005-08-17
Accepted
2005-08-17 16:47:05
Documents
6
Period of Report
2004-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 20-F f20-chinapharm.txt 20-F 123992
2 EXH 4-5 AGREEMENT exhibit-agmt.txt EX-10 68472
3 EXH 12-1 CERTIFICATION exh12-1_certification.txt EX-31 4400
4 EXH 12-2 CERTIFICATION exh12-2_certification.txt EX-31 4413
5 EXH 13-1 CERTIFICATION exh13-1_certification.txt EX-32 1238
6 EXH 13-2 CERTIFICATION exh13-2_certification.txt EX-32 1243
  Complete submission text file 0000949353-05-000318.txt   205684
Mailing Address UNIT 3611, 36/F, WEST TOWER 168-200 CONNAUGHT ROAD CENTRAL HONG KONG K3 NONE
Business Address UNIT 3611, 36/F, WEST TOWER 168-200 CONNAUGHT ROAD CENTRAL HONG KONG K3 NONE 85222550688
CHINA PHARMACEUTICALS INTERNATIONAL CORP (Filer) CIK: 0001081823 (see all company filings)

IRS No.: 980348508 | State of Incorp.: D8 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 000-28879 | Film No.: 051033806
SIC: 7389 Services-Business Services, NEC